Affordable Access

deepdyve-link
Publisher Website

Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series.

Authors
  • Gelfand, Jeffrey M1
  • Bradshaw, Michael J1
  • Stern, Barney J1
  • Clifford, David B1
  • Wang, Yunxia1
  • Cho, Tracey A1
  • Koth, Laura L1
  • Hauser, Stephen L1
  • Dierkhising, Jason1
  • Vu, NgocHanh1
  • Sriram, Subramaniam1
  • Moses, Harold1
  • Bagnato, Francesca1
  • Kaufmann, Jeffrey A1
  • Ammah, Deidre J1
  • Yohannes, Tsion H1
  • Hamblin, Mark J1
  • Venna, Nagagopal1
  • Green, Ari J1
  • Pawate, Siddharama2
  • 1 From the Department of Neurology (J.M.G., S.L.H., J.D., A.J.G.), Division of Pulmonary and Critical Care, Department of Medicine (L.L.K.), and Department of Ophthalmology (A.J.G.), University of California San Francisco; Department of Neurology (M.J.B., N.V., S.S., H.M., F.B., S.P.), Vanderbilt University Medical Center, Nashville, TN; Department of Neurology (B.J.S., J.A.K., D.J.A.), University of Maryland Medical Center, Baltimore; Departments of Neurology and Medicine (D.B.C., T.H.Y.), Washington University in St. Louis, MO; Department of Neurology (Y.W., M.J.H.), University of Kansas Medical Center, Kansas City; and Department of Neurology (T.A.C., N.V.), Massachusetts General Hospital, Boston.
  • 2 From the Department of Neurology (J.M.G., S.L.H., J.D., A.J.G.), Division of Pulmonary and Critical Care, Department of Medicine (L.L.K.), and Department of Ophthalmology (A.J.G.), University of California San Francisco; Department of Neurology (M.J.B., N.V., S.S., H.M., F.B., S.P.), Vanderbilt University Medical Center, Nashville, TN; Department of Neurology (B.J.S., J.A.K., D.J.A.), University of Maryland Medical Center, Baltimore; Departments of Neurology and Medicine (D.B.C., T.H.Y.), Washington University in St. Louis, MO; Department of Neurology (Y.W., M.J.H.), University of Kansas Medical Center, Kansas City; and Department of Neurology (T.A.C., N.V.), Massachusetts General Hospital, Boston. [email protected]
Type
Published Article
Journal
Neurology
Publisher
Ovid Technologies (Wolters Kluwer) - American Academy of Neurology
Publication Date
Nov 14, 2017
Volume
89
Issue
20
Pages
2092–2100
Identifiers
DOI: 10.1212/WNL.0000000000004644
PMID: 29030454
Source
Medline
License
Unknown

Abstract

This study provides Class IV evidence that for patients with CNS sarcoidosis infliximab is associated with favorable imaging and clinical responses.

Report this publication

Statistics

Seen <100 times